/Companies

Genalyte

San Diego, US · 94 employees on LinkedIn · 14 known investors

Find your way into Genalyte

Each arrow is one introduction. Sign up to fill in the first one.

160 people can intro you to Cary

Ask Jeff Huber to introduce you to Cary Gunn

You →Jeff · together at Genalyte →Cary

Sign up to find every way you can get introduced to Genalyte

  • Your email: who you already know at Genalyte, and who your contacts know
  • 2nd- and 3rd-degree connections: people you know who worked, studied or invested with the Genalyte team
  • Your LinkedIn: the connections who can make the intro for you

We rank every route by how warm it is, so you raise on warm intros instead of cold emails.

Genalyte develops Merlin, a real-time diagnostic system that performs laboratory testing directly in clinical settings and integrates results with electronic health records. The company serves healthcare providers including primary care clinics, hospitals, surgery centers, and military facilities.

Founders & leadership

CGCary Gunn
Cary GunnFounderCary Gunn is co-founder and CTO of Genalyte, which develops a real-time diagnostic system for clinical settings using silicon photonics technology. Previously, he co-founded Luxtera, a company focused on silicon photonics chips for networking applications.

Investors · 14

Funding

SEC filings, press & company announcements

$36M disclosed across 1 of 2 rounds · 2016–2021

Source: company announcements and press reports — follow each round's link for the claim.

Founder mafia

2 people who came through Genalyte went on to found or lead other companies.

Non-dilutive funding · 3 SBIR/STTR awards

Federal grants — no equity taken
AgencyPhaseYearAmount
National Institutes of Health (NIH)National Institutes of HealthPhase II2013$999.2K
National Institutes of Health (NIH)National Institutes of HealthPhase I2012$523.5K
National Institutes of Health (NIH)National Institutes of HealthPhase I2011$199.9K

Source: SBIR.gov award data (U.S. Small Business Administration). SBIR/STTR awards are competitive federal R&D grants and contracts — non-dilutive capital alongside any venture rounds above.

In the news

Frequently asked questions

What does Genalyte do?
Genalyte develops Merlin, a real-time diagnostic system that performs laboratory testing directly in clinical settings and integrates results with electronic health records. The company serves healthcare providers including primary care clinics, hospitals, surgery centers, and military facilities.
Who founded Genalyte?
Genalyte was founded by Cary Gunn.
Who are Genalyte's investors?
Genalyte's investors include BioBrit, Boutique Venture Partners, Claremont Creek Ventures, CLI Ventures, FusionX Ventures, HBM Healthcare Investments, HBM Partners, IPD Capital and 6 more.
How much funding has Genalyte raised?
Genalyte has disclosed $36M raised across 1 of its 2 known rounds.
Where is Genalyte headquartered?
Genalyte is headquartered in San Diego, US.